# Comparison of the Efficacy and Tolerability of Black Cohosh Vs Tibolone in Patients With Menopausal Symptoms

> **NCT00299364** · PHASE3 · COMPLETED · sponsor: **Schaper & Bruemmer GmbH & Co KG** · enrollment: 240 (—)

## Conditions studied

- Menopause

## Interventions

- **DRUG:** Black Cohosh (iCR) or tibolone

## Key facts

- **NCT ID:** NCT00299364
- **Lead sponsor:** Schaper & Bruemmer GmbH & Co KG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2005-05
- **Target enrollment:** 240 (—)
- **Last updated:** 2006-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00299364

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00299364, "Comparison of the Efficacy and Tolerability of Black Cohosh Vs Tibolone in Patients With Menopausal Symptoms". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00299364. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*